IBKS No2 SPAC (204840) - Total Liabilities

Latest as of March 2026: ₩28.80 Billion KRW ≈ $19.52 Million USD

Based on the latest financial reports, IBKS No2 SPAC (204840) has total liabilities worth ₩28.80 Billion KRW (≈ $19.52 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of IBKS No2 SPAC to track the company's year-over-year net asset growth rate.

IBKS No2 SPAC - Total Liabilities Trend (2015–2025)

This chart illustrates how IBKS No2 SPAC's total liabilities have evolved over time, based on quarterly financial data. See IBKS No2 SPAC free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

IBKS No2 SPAC Competitors by Total Liabilities

The table below lists competitors of IBKS No2 SPAC ranked by their total liabilities.

Company	Country	Total Liabilities
Cryosite Ltd AU:CTE	Australia	AU$22.94 Million
Cyan AG XETRA:CYR	Germany	€3.63 Million
Senko Co. Ltd KQ:347000	Korea	₩13.99 Billion
Pembangunan Jaya Ancol Tbk JK:PJAA	Indonesia	Rp1.70 Trillion
Wing Yip Food (China) Holdings Group Limited KQ:900340	Korea	₩42.79 Million
Korea Computer Inc KQ:054040	Korea	₩132.34 Billion
Me2on Co. Ltd KQ:201490	Korea	₩22.72 Billion
Heritage Global Inc NASDAQ:HGBL	USA	$17.22 Million

Liability Composition Analysis (2015–2025)

This chart breaks down IBKS No2 SPAC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see IBKS No2 SPAC market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.95	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.45	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.59	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how IBKS No2 SPAC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for IBKS No2 SPAC (2015–2025)

The table below shows the annual total liabilities of IBKS No2 SPAC from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩28.90 Billion ≈ $19.58 Million	+26.89%
2024-12-31	₩22.77 Billion ≈ $15.43 Million	-17.45%
2023-12-31	₩27.59 Billion ≈ $18.69 Million	+11.40%
2022-12-31	₩24.76 Billion ≈ $16.78 Million	+64.59%
2021-12-31	₩15.05 Billion ≈ $10.20 Million	-27.07%
2020-12-31	₩20.63 Billion ≈ $13.98 Million	-14.70%
2019-12-31	₩24.19 Billion ≈ $16.39 Million	+1.86%
2018-12-31	₩23.74 Billion ≈ $16.09 Million	+161.34%
2017-12-31	₩9.09 Billion ≈ $6.16 Million	+140.17%
2016-12-31	₩3.78 Billion ≈ $2.56 Million	-33.42%
2015-12-31	₩5.68 Billion ≈ $3.85 Million	--

About IBKS No2 SPAC

KQ:204840 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$43.12 Million

₩63.63 Billion KRW

Market Cap Rank

#22436 Global

#1404 in Korea

Share Price

₩824.00

Change (1 day)

-2.14%

52-Week Range

₩780.00 - ₩1274.00

All Time High

₩8655.23